SCHEMBL30830603

SCHEMBL30830603

CN1C[C@H](Nc2cnn(C)c(=O)c2Br)C[C@H](c2ccc(C(=O)N3CCC4(CC3)CCN(c3ccc([C@H]5CCC(=O)NC5=O)cc3)CC4)cc2)C1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KAT2B Q92831 12/20 0.51
▸ BRD9 Q9H8M2 3/20 0.51
▸ KAT2A Q92830 2/20 0.51
▸ BRD1 O95696 1/20 0.51
▸ ACHE P22303 1/20 0.51
▸ BRPF1 P55201 1/20 0.51
▸ BPTF Q12830 1/20 0.51
▸ BRD7 Q9NPI1 1/20 0.51
▸ BAZ2B Q9UIF8 1/20 0.51
▸ BRPF3 Q9ULD4 1/20 0.51
▸ CRBN Q96SW2 2/20 0.33
▸ CYP3A4 P08684 4/20 0.33
▸ AR P10275 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ USP2 O75604 2/20 0.32
▸ SMN1; SMN2 Q16637 2/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30830728 1.00 KAT2B (0.51) KAT2BBRD9KAT2ABRD1ACHE
SCHEMBL30831002 1.00 KAT2B (0.51) KAT2BBRD9KAT2ABRD1ACHE
SCHEMBL30830519 0.95 KAT2B (0.50) KAT2BBRD9KAT2ABRD1ACHE
SCHEMBL30830595 0.95 KAT2B (0.50) KAT2BBRD9KAT2ABRD1ACHE
SCHEMBL30830740 0.94 KAT2B (0.49) KAT2BBRD9KAT2ABRD1ACHE
SCHEMBL31091718 0.94 KAT2B (0.43) KAT2BBRD9KAT2ABRD1ACHE
SCHEMBL30830850 0.94 KAT2B (0.53) KAT2BBRD9KAT2ABRD1ACHE
SCHEMBL30830721 0.93 KAT2B (0.51) KAT2BBRD9KAT2ABRD1ACHE
SCHEMBL30830799 0.93 KAT2B (0.41) KAT2BBRD9KAT2ABRD1ACHE
SCHEMBL30830776 0.92 KAT2B (0.51) KAT2BBRD9KAT2ABRD1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581025-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Auron Therapeutics, Inc. (US) 2025-07-09 — — EP disclosed
WO-2024220843-A1 TECHNOLOGIES TARGETING CELL STATES AURON THERAPEUTICS, INC. (US) 2024-10-24 — — WO disclosed
WO-2024050078-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS AURON THERAPEUTICS, INC. (US) 2024-03-07 — — WO disclosed
Send feedback